FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3138902078> ?p ?o ?g. }

• W3138902078 endingPage "e0009204" @default.
• W3138902078 startingPage "e0009204" @default.
• W3138902078 abstract "Background A higher caseload of visceral leishmaniasis (VL) has been observed among males in community-based surveys. We carried out this review to investigate how the observed disparity in gender distribution is reflected in clinical trials of antileishmanial therapies. Methods We identified relevant studies by searching a database of all published clinical trials in VL from 1980 through 2019 indexed in the Infectious Diseases Data Observatory (IDDO) VL clinical trials library. The proportion of male participants enrolled in studies eligible for inclusion in this review were extracted and combined using random effects meta-analysis of proportion. Results were expressed as percentages and presented with respective 95% confidence intervals (95% CIs). Heterogeneity was quantified using I 2 statistics and sub-group meta-analyses were carried out to explore the sources of heterogeneity. Results We identified 135 published studies (1980–2019; 32,177 patients) with 68.0% [95% CI: 65.9%–70.0%; I 2 = 92.6%] of the enrolled participants being males. The corresponding estimates were 67.6% [95% CI: 65.5%–69.7%; n = 91 trials; I 2 = 90.5%; 24,218 patients] in studies conducted in the Indian sub-continent and 74.1% [95% CI: 68.4%–79.1%; n = 24 trials; I 2 = 94.4%; 6,716 patients] in studies from Eastern Africa. The proportion of male participants was 57.9% [95% CI: 54.2%–61.5%] in studies enrolling children aged <15 years, 78.2% [95% CI: 66.0%–86.9%] in studies that enrolled adults (≥15 years), and 68.1% [95% CI: 65.9%–70.0%] in studies that enrolled patients of all ages. There was a trend for decreased proportions of males enrolled over time: 77.1% [95% CI: 70.2%–82.8%; 1356 patients] in studies published prior to the 1990s whereas 64.3% [95% CI: 60.3%–68.2%; 15,611 patients] in studies published on or after 2010. In studies that allowed the inclusion of patients with HIV co-infections, 76.5% [95% CI: 63.8%–85.9%; 5,123 patients] were males and the corresponding estimate was 64.0% [95% CI: 61.4%–66.5% 17,500 patients] in studies which excluded patients with HIV co-infections. Conclusions Two-thirds of the participants enrolled in clinical studies in VL conducted in the past 40 years were males, though the imbalance was less in children and in more recent trials. VL treatment guidelines are informed by the knowledge of treatment outcomes from a population that is heavily skewed towards adult males. Investigators planning future studies should consider this fact and ensure approaches for more gender-balanced inclusion." @default.
• W3138902078 created "2021-03-29" @default.
• W3138902078 creator A5002458341 @default.
• W3138902078 creator A5043639661 @default.
• W3138902078 creator A5047204174 @default.
• W3138902078 creator A5054185332 @default.
• W3138902078 date "2021-03-16" @default.
• W3138902078 modified "2023-10-02" @default.
• W3138902078 title "Gender disparity in cases enrolled in clinical trials of visceral leishmaniasis: A systematic review and meta-analysis" @default.
• W3138902078 cites W1959145249 @default.
• W3138902078 cites W1968830487 @default.
• W3138902078 cites W1982569141 @default.
• W3138902078 cites W1988358693 @default.
• W3138902078 cites W1993870810 @default.
• W3138902078 cites W1994112095 @default.
• W3138902078 cites W2002259425 @default.
• W3138902078 cites W2002973770 @default.
• W3138902078 cites W2015273007 @default.
• W3138902078 cites W2022956687 @default.
• W3138902078 cites W2030813834 @default.
• W3138902078 cites W2034317610 @default.
• W3138902078 cites W2057222889 @default.
• W3138902078 cites W2060306494 @default.
• W3138902078 cites W2062385497 @default.
• W3138902078 cites W2070833616 @default.
• W3138902078 cites W2093657497 @default.
• W3138902078 cites W2094329808 @default.
• W3138902078 cites W2101502132 @default.
• W3138902078 cites W2125222375 @default.
• W3138902078 cites W2126930838 @default.
• W3138902078 cites W2128483376 @default.
• W3138902078 cites W2137600992 @default.
• W3138902078 cites W2264702947 @default.
• W3138902078 cites W2515900149 @default.
• W3138902078 cites W2519666645 @default.
• W3138902078 cites W2740883688 @default.
• W3138902078 cites W2770254547 @default.
• W3138902078 cites W2771492402 @default.
• W3138902078 cites W2912914382 @default.
• W3138902078 cites W2955289620 @default.
• W3138902078 cites W3003636929 @default.
• W3138902078 cites W4248467013 @default.
• W3138902078 cites W4252529904 @default.
• W3138902078 doi "https://doi.org/10.1371/journal.pntd.0009204" @default.
• W3138902078 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7963105" @default.
• W3138902078 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33725005" @default.
• W3138902078 hasPublicationYear "2021" @default.
• W3138902078 type Work @default.
• W3138902078 sameAs 3138902078 @default.
• W3138902078 citedByCount "11" @default.
• W3138902078 countsByYear W31389020782021 @default.
• W3138902078 countsByYear W31389020782022 @default.
• W3138902078 countsByYear W31389020782023 @default.
• W3138902078 crossrefType "journal-article" @default.
• W3138902078 hasAuthorship W3138902078A5002458341 @default.
• W3138902078 hasAuthorship W3138902078A5043639661 @default.
• W3138902078 hasAuthorship W3138902078A5047204174 @default.
• W3138902078 hasAuthorship W3138902078A5054185332 @default.
• W3138902078 hasBestOaLocation W31389020781 @default.
• W3138902078 hasConcept C126322002 @default.
• W3138902078 hasConcept C144024400 @default.
• W3138902078 hasConcept C149923435 @default.
• W3138902078 hasConcept C203014093 @default.
• W3138902078 hasConcept C2776555147 @default.
• W3138902078 hasConcept C2778689377 @default.
• W3138902078 hasConcept C44249647 @default.
• W3138902078 hasConcept C535046627 @default.
• W3138902078 hasConcept C71924100 @default.
• W3138902078 hasConcept C95190672 @default.
• W3138902078 hasConceptScore W3138902078C126322002 @default.
• W3138902078 hasConceptScore W3138902078C144024400 @default.
• W3138902078 hasConceptScore W3138902078C149923435 @default.
• W3138902078 hasConceptScore W3138902078C203014093 @default.
• W3138902078 hasConceptScore W3138902078C2776555147 @default.
• W3138902078 hasConceptScore W3138902078C2778689377 @default.
• W3138902078 hasConceptScore W3138902078C44249647 @default.
• W3138902078 hasConceptScore W3138902078C535046627 @default.
• W3138902078 hasConceptScore W3138902078C71924100 @default.
• W3138902078 hasConceptScore W3138902078C95190672 @default.
• W3138902078 hasFunder F4320307874 @default.
• W3138902078 hasIssue "3" @default.
• W3138902078 hasLocation W31389020781 @default.
• W3138902078 hasLocation W31389020782 @default.
• W3138902078 hasLocation W31389020783 @default.
• W3138902078 hasOpenAccess W3138902078 @default.
• W3138902078 hasPrimaryLocation W31389020781 @default.
• W3138902078 hasRelatedWork W1139037058 @default.
• W3138902078 hasRelatedWork W2026378453 @default.
• W3138902078 hasRelatedWork W2150604586 @default.
• W3138902078 hasRelatedWork W2526654304 @default.
• W3138902078 hasRelatedWork W2790827978 @default.
• W3138902078 hasRelatedWork W2975498416 @default.
• W3138902078 hasRelatedWork W3159545061 @default.
• W3138902078 hasRelatedWork W324504601 @default.
• W3138902078 hasRelatedWork W2184475467 @default.
• W3138902078 hasRelatedWork W2903040050 @default.
• W3138902078 hasVolume "15" @default.
• W3138902078 isParatext "false" @default.

• next